RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. It operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: RDNT
- Previous Close: $6.25
- 50 Day Moving Average: $6.08
- 200 Day Moving Average: $6.56
- 52-Week Range: $46,467,000.00 - $4.66
- Trailing P/E Ratio: 64.58
- Foreward P/E Ratio: 16.76
- P/E Growth: 2.50
- Market Cap: $288.10M
- Outstanding Shares: 46,467,000
- Beta: 1.4
- Net Margins: 0.51%
- Return on Equity: 22.29%
- Return on Assets: 1.00%
Companies Related to RadNet:
- Debt-to-Equity Ratio: 15.38%
- Current Ratio: 1.56%
- Quick Ratio: 1.56%
What is RadNet's stock symbol?
RadNet trades on the NASDAQ under the ticker symbol "RDNT."
Where is RadNet's stock going? Where will RadNet's stock price be in 2017?
5 analysts have issued 1-year price targets for RadNet's shares. Their predictions range from $7.00 to $9.00. On average, they anticipate RadNet's stock price to reach $8.33 in the next twelve months.
When will RadNet announce their earnings?
RadNet is scheduled to release their next quarterly earnings announcement on Monday, March, 13th 2017.
Who owns RadNet stock?
RadNet's stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (2.96%), State Street Corp (1.32%), Renaissance Technologies LLC (1.23%), Allianz Asset Management AG (0.59%), Oxford Asset Management (0.46%) and Cadence Capital Management LLC (0.28%). Company insiders that own RadNet stock include Jeffrey L Linden, John V Crues, Mark Stolper, Michael N Murdock, Norman R Hames, Stephen M Forthuber and Todd W Skulte.
Who sold RadNet stock? Who is selling RadNet stock?
RadNet's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Oxford Asset Management, AQR Capital Management LLC, Brown Advisory Inc., Two Sigma Investments LP and Metropolitan Life Insurance Co. NY. Company insiders that have sold RadNet stock in the last year include Jeffrey L Linden, Mark Stolper, Norman R Hames and Stephen M Forthuber.
Who bought RadNet stock? Who is buying RadNet stock?
RadNet's stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Dimensional Fund Advisors LP, State Board of Administration of Florida Retirement System, State Street Corp, A.R.T. Advisors LLC, GSA Capital Partners LLP and Cadence Capital Management LLC.
How do I buy RadNet stock?
Shares of RadNet can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of RadNet stock cost?
One share of RadNet stock can currently be purchased for approximately $6.20.